Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05503797
Title	A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Recruitment	Recruiting
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Fore Biotherapeutics
Indications	anaplastic astrocytoma ganglioglioma central nervous system cancer pilocytic astrocytoma anaplastic oligodendroglioma gliosarcoma high grade glioma glioblastoma anaplastic pleomorphic xanthoastrocytoma high-grade astrocytoma with piloid features
Therapies	Cobicistat + PLX8394 PLX8394
Age Groups:	child \| adult \| senior
Covered Countries	USA \| SWE \| ITA \| GBR \| FRA \| ESP \| DEU \| CAN